Cleared Special

K993666 - DISETRONIC PEN P100

K993666 is an FDA 510(k) clearance for DISETRONIC PEN P100, manufactured by Disetronic Medical Systems. The device is a Class 2 General Hospital device with product code FMF cleared through the Special 510(k) pathway after a 21-day FDA review.

K993666 · Disetronic Medical Systems · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1999
Decision
21d
Days
Class 2
Risk

K993666 is an FDA 510(k) clearance for the DISETRONIC PEN P100. Classified as Syringe, Piston (product code FMF), Class II - Special Controls.

Submitted by Disetronic Medical Systems (Fort Myers, US). The FDA issued a Cleared decision on November 22, 1999 after a review of 21 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5860 - the FDA general hospital device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Disetronic Medical Systems devices

FDA 510(k) Submission Details - K993666

510(k) Number K993666 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 01, 1999
Decision Date November 22, 1999
Days to Decision 21 days
Submission Type Special
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
108d faster than avg
Panel avg: 129d · This submission: 21d
Pathway characteristics
Modification to existing cleared device.

FMF Device Classification - Class 2, Special Controls

Product Code FMF Syringe, Piston
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5860
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMF Syringe, Piston

All 357
Devices cleared under the same product code (FMF) and FDA review panel - the closest regulatory comparables to K993666.
TERUMO U-100 INSULIN SYRING
K001474 · Terumo Medical Corp. · Jun 2000
NIPRO INSULIN SYRINGE
K000144 · Nipro Medical Corp. · Feb 2000
VACLOK SYRINGE
K994253 · Merit Medical Systems, Inc. · Jan 2000
TERUMO U-100 INSULIN SYRINGE
K992802 · Terumo Medical Corp. · Sep 1999
MTI 1 ML SYRINGE
K991225 · Micro Therapeutics, Inc. · Jul 1999
MONOJECT INSULIN SYRINGE
K991758 · The Kendal Co. · Jun 1999